BIOTECH GROWTH N V - 18 Aug 2021 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role: 10%+ Owner
Signature: /s/ Daniel Koller
Issuer symbol: EPIX
Transactions as of: 18 Aug 2021
Transactions value $: $2,218,800
Form type: 4
Filing time: 20 Aug 2021, 12:43:51 UTC
Previous filing: 17 Aug 2021
Next filing: 13 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EPIX	Common Shares	Purchase	$2.22M	+250K	+5.25%	$8.88	5.02M	18 Aug 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of ESSA Pharma Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.